Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sudden Acceleration of Diabetes Quality Measures

Sudden Acceleration of Diabetes Quality Measures COMMENTARY Sudden Acceleration of Diabetes Quality Measures sota Community Measurement Program developed a com- Leonard Pogach, MD, MBA posite measure, termed the Diabetes 5 (D5), that was based David C. Aron, MD, MS on these optimal measures for HbA , blood pressure, and 1c LDL-C; administration of aspirin; and nonsmoking status. HE MODERN ERA IN DIABETES PERFORMANCE MEA- Despite unanimous opposition from the Technical Ad- surement began in 1997, when the Diabetes Qual- visory Panel of the Alliance, the NCQA approved the opti- ity Improvement Project (DQIP), the first national mal measure set in May 2006. Even though inconsistent Tdisease-specific measure, set recommended thresh- with guidelines from nonspecialty societies, these mea- olds for intermediate outcomes (glycated hemoglobin [HbA ] sures were widely viewed as evidence-based standards of care 1c levels, blood pressure, and low-density lipoprotein choles- because they were based on the guidelines of specialty so- terol [LDL-C] levels). These thresholds, if not achieved, cieties that lent their leadership to the industry-sponsored would clearly result in greater population morbidity and mor- public service campaign. tality. The DQIP explicitly stated that such threshold mea- Coincidentally, 1 week after approval of the optimal mea- sures were neither guidelines nor standards and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Sudden Acceleration of Diabetes Quality Measures

JAMA , Volume 305 (7) – Feb 16, 2011

Loading next page...
 
/lp/american-medical-association/sudden-acceleration-of-diabetes-quality-measures-nejnq59ixv
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2011.153
pmid
21325188
Publisher site
See Article on Publisher Site

Abstract

COMMENTARY Sudden Acceleration of Diabetes Quality Measures sota Community Measurement Program developed a com- Leonard Pogach, MD, MBA posite measure, termed the Diabetes 5 (D5), that was based David C. Aron, MD, MS on these optimal measures for HbA , blood pressure, and 1c LDL-C; administration of aspirin; and nonsmoking status. HE MODERN ERA IN DIABETES PERFORMANCE MEA- Despite unanimous opposition from the Technical Ad- surement began in 1997, when the Diabetes Qual- visory Panel of the Alliance, the NCQA approved the opti- ity Improvement Project (DQIP), the first national mal measure set in May 2006. Even though inconsistent Tdisease-specific measure, set recommended thresh- with guidelines from nonspecialty societies, these mea- olds for intermediate outcomes (glycated hemoglobin [HbA ] sures were widely viewed as evidence-based standards of care 1c levels, blood pressure, and low-density lipoprotein choles- because they were based on the guidelines of specialty so- terol [LDL-C] levels). These thresholds, if not achieved, cieties that lent their leadership to the industry-sponsored would clearly result in greater population morbidity and mor- public service campaign. tality. The DQIP explicitly stated that such threshold mea- Coincidentally, 1 week after approval of the optimal mea- sures were neither guidelines nor standards and

Journal

JAMAAmerican Medical Association

Published: Feb 16, 2011

References